labetalol hydrochloride
Generic: labetalol hydrochloride
Labeler: hospira, inc.Drug Facts
Product Profile
Brand Name
labetalol hydrochloride
Generic Name
labetalol hydrochloride
Labeler
hospira, inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
labetalol hydrochloride 5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0409-0125
Product ID
0409-0125_c1772ea4-65eb-4f27-8e33-3de06278acfe
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075240
Listing Expiration
2026-12-31
Marketing Start
2023-08-07
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04090125
Hyphenated Format
0409-0125
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
labetalol hydrochloride (source: ndc)
Generic Name
labetalol hydrochloride (source: ndc)
Application Number
ANDA075240 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/mL
Packaging
- 25 VIAL, MULTI-DOSE in 1 TRAY (0409-0125-25) / 20 mL in 1 VIAL, MULTI-DOSE (0409-0125-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "c1772ea4-65eb-4f27-8e33-3de06278acfe", "openfda": {"unii": ["1GEV3BAW9J"], "rxcui": ["896771"], "spl_set_id": ["abfc6b75-1ed5-41f1-0484-4597488237bc"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, MULTI-DOSE in 1 TRAY (0409-0125-25) / 20 mL in 1 VIAL, MULTI-DOSE (0409-0125-01)", "package_ndc": "0409-0125-25", "marketing_start_date": "20230807"}], "brand_name": "Labetalol Hydrochloride", "product_id": "0409-0125_c1772ea4-65eb-4f27-8e33-3de06278acfe", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "0409-0125", "generic_name": "Labetalol Hydrochloride", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Labetalol Hydrochloride", "active_ingredients": [{"name": "LABETALOL HYDROCHLORIDE", "strength": "5 mg/mL"}], "application_number": "ANDA075240", "marketing_category": "ANDA", "marketing_start_date": "20230807", "listing_expiration_date": "20261231"}